AstraZeneca has opened a new global strategic R&D facility in Massachusetts, US, as part of an investment of more than $1bn in the state.

The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, as pharma explores its role on treating ophthalmic conditions.

The US FDA has expanded the approved indication for BMS' Camzyos to treat symptomatic oHCM in adults and paediatric patients weighing at least 30 kg.

Summit is currently developing Ivonescimab in combination with other drugs across several types of solid tumours.

Established CDMO Piramal Pharma Solutions is exhibiting at the forthcoming CPHI Milan 2026. The event will showcase the latest innovations in drug development, manufacturing, supply chains, and ...

Unlike other therapies in this class, Abogen’s ABO2203 is designed to produce a T-cell engager protein in vivo through an mRNA-encoded system.

Varda secures this capital as drugmakers tout the potential of manufacturing in microgravity conditions to create differentiated medicines.

Having already brought one of the most successful drugs in the world to market, Sanofi and Regeneron are broadening their pipeline horizon – the companies have agreed to expand ...

Key themes of CPHI 2026, the GLP-1 manufacturing shift, cold chain logistics, and more.

Illustration of New Albany International Business Park. Credit: Bayer AG. This investment adds to more than $7bn spent by the company on pharmaceutical research, development, and manufacturing in the ...

OBIO delivers infrastructure, advocacy, and strategic programming across the medtech, digital health, therapeutics, and diagnostic fields. Credit: Gorodenkoff ...